Managing IP Finds Bill Lee Among Top 10 Litigators in Life Sciences Patent Industry

Download IconDownload Print IconPrint

Managing IP Finds Bill Lee Among Top 10 Litigators in Life Sciences Patent Industry

Attorney News

Related Solutions

Providing comprehensive solutions for the acquisition, enforcement and protection of IP.

By patenting their innovations, our clients increase the value of their intellectual property and enhance their ability to compete in the marketplace. We work with laboratory and research teams and R&D and product development groups to determine whether, when and where it is in our clients’ business and technical interests to seek patent protection. And we don’t just file patent applications. Drawing on our experience with patent litigation, corporate financings and technology transactions, we implement IP strategies that conserve resources, add measurable value and give our clients a cost-effective and commercially practical competitive edge.

We help clients obtain more than 750 US and foreign patents each year, covering innovations that span the technological spectrum, including aerospace, biochemistry, biotechnology, business methods, chemistry, computer science, fuel cells, genetics, high-speed data communication, integrated circuits, materials science, medical devices, nanotechnology, pharmaceuticals, semiconductor devices and processes, and software.

We also prepare and prosecute patent applications internationally under the Patent Cooperative Treaty and by working with a network of seasoned patent lawyers around the world. Our experience extends to appeals, interferences and opposition proceedings within the US Patent and Trademark Office, the US Court of Appeals for the Federal Circuit and the European Patent Office.

Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
The June 2012 issue of Managing IP magazine includes Partner and Former Co-Managing Partner Bill Lee as one of only 10 individuals to be named as a top litigator in the Life Sciences Patent industry in the United States. This recognition comes not long after being selected as one of eight finalists in the The American Lawyer’s “Litigator of the Year” contest in January 2012.

Lee has tried more than 100 patent cases, both jury and jury waived, to judgment and argued more than 50 appeals before the Court of Appeals for the Federal Circuit and other courts of appeals. His recent life sciences clients include Abbott Laboratories, for whom he obtained a significant victory in the United States Court of Appeals for the Federal Circuit with the complete reversal of a $1.67 billion patent-infringement verdict; and Nycomed GmbH and Wyeth, on behalf of whom Lee achieved a jury verdict in the United States District Court for the District of New Jersey upholding the validity of a patent covering the active ingredient in the blockbuster gastric acid disorder treatment PROTONIX in the face of a challenge by companies that had launched generic versions of the drug before patent expiration.

The selection of Managing IP’s “Top 10” litigators is based off of the research conducted for the recently announced LMG Life Sciences 2012 directory, in which the firm was found to be “highly recommended” for general patent litigation and as “recommended” for Hatch-Waxman patent litigation.

For more information on Managing IP magazine, click here.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel